Lipid-lowering Effect of Plant Stanol Yogurt

Inclusion Criteria: * subjects must voluntarily sign the informed consent * subjects must be male or female aged 20 to 70 years * subjects must have a serum total cholesterol concentration of 5.2 - 7.5 mmol/l ( 205 - 290 mg/dl) at the screening visit (visit 1, -2 week) Exclusion Criteria: * subjects using lipid lowering medication * subjects using ezetimibe * subjects with bile acid sequestrant medication * subjects with statin therapy * subjects using other medication significantly influencing on lipid values * subjects with diagnosis type 1 or type 2 diabetes * severe obesity (BMI\>35.0 kg/m2) * serum fasting triglycerides \> 4.0 mmol/l * subjects with any hepatic or renal disorder according to medical history * subjects who have history of myocardial infarction or unstable angina pectoris within six months prior to screening * subjects who have history of coronary artery bypass graft or percutaneous transluminal coronary angioplasty within six months prior to screening * subjects who have history of temporal ischemic attack or stroke within six months prior to screening * subjects who have a history of cancer or other malignant disease within the past five years * subjects with abnormal values of health screening variables measured at screening visit: serum gamma-glutamyltransferase\> 2 x upper limit, serum alkaline phosphatase\> 2 x upper limit or other abnormality in laboratory evaluations considered as clinically significant in the opinion of the study physician * subjects who are consuming more than 15 portions of alcohol / week * subjects who are pregnant or lactating * subjects using Benecol, Becelpro.activ, Danacol or other plant sterol enriched products within 30 days before visit 2 * subjects with severe lactose intolerance, milk allergy or any other intolerance to the ingredients of test products * celiac disease